HR 526
A Resolution recognizing the month of May 2026 as "Guillain-Barré Syndrome Awareness Month" in Pennsylvania.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This resolution designates May 2026 as "Guillain-Barré Syndrome Awareness Month" in Pennsylvania. It highlights the rare autoimmune condition GBS, its symptoms, and the ongoing research efforts to understand and treat it. The resolution aims to raise awareness of GBS and support continued research into the disease.
Key provisions
- Designates May 2026 as "Guillain-Barré Syndrome Awareness Month" in Pennsylvania.
- Recognizes Guillain-Barré syndrome (GBS) as a rare autoimmune condition affecting the peripheral nerves.
- Acknowledges the impact of GBS, including potential for muscle paralysis and the need for hospitalization.
- Highlights ongoing research efforts by the National Institutes of Health and the World Health Organization.
- Mentions the role of organizations like the GBS-CIDP Foundation International in raising awareness.
Who is affected
- Individuals with Guillain-Barré Syndrome
- Families and caregivers of individuals with GBS
- Healthcare professionals involved in the treatment of neurological disorders
Notable changes
- This resolution specifically focuses on raising awareness of GBS within Pennsylvania.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Benjamin Sanchez
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yours